U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C55H59N5O20
Molecular Weight 1110.0785
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of COUMERMYCIN

SMILES

CO[C@@H]1[C@@H](OC(=O)C2=CC=C(C)N2)[C@@H](O)[C@H](OC3=C(C)C4=C(C=C3)C(O)=C(NC(=O)C5=CNC(C(=O)NC6=C(O)C7=C(OC6=O)C(C)=C(O[C@@H]8OC(C)(C)[C@H](OC)[C@@H](OC(=O)C9=CC=C(C)N9)[C@H]8O)C=C7)=C5C)C(=O)O4)OC1(C)C

InChI

InChIKey=WTIJXIZOODAMJT-DHFGXMAYSA-N
InChI=1S/C55H59N5O20/c1-21-12-16-29(57-21)48(67)77-42-38(63)52(79-54(6,7)44(42)71-10)73-31-18-14-26-36(61)34(50(69)75-40(26)24(31)4)59-46(65)28-20-56-33(23(28)3)47(66)60-35-37(62)27-15-19-32(25(5)41(27)76-51(35)70)74-53-39(64)43(45(72-11)55(8,9)80-53)78-49(68)30-17-13-22(2)58-30/h12-20,38-39,42-45,52-53,56-58,61-64H,1-11H3,(H,59,65)(H,60,66)/t38-,39-,42+,43+,44-,45-,52-,53-/m1/s1

HIDE SMILES / InChI

Molecular Formula C55H59N5O20
Molecular Weight 1110.0785
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Coumermycin is from the aminocoumarin class of antibiotic compounds which acts by inhibiting DNA gyrase. Coumermycin is effective against gram-positive bacteria, but not gram-negative bacteria. Coumermycin its derivatives have been studied since the 1950's as potential antibiotic. However, it has seen little to no clinical development because of its low water solubility, toxicity profile, and ineffectiveness against gram-negative bacteria.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Efficacy of coumermycin, ofloxacin and vancomycin against methicillin-resistant Staphylococcus aureus in vitro and in experimental infections of mice.
1988 Mar
Combinatorial biosynthesis, metabolic engineering and mutasynthesis for the generation of new aminocoumarin antibiotics.
2008
Patents

Sample Use Guides

Lethal septicemia was induced in mice by intraperitoneal administration of Methicillin-Resistant Staphylococcus. The infection was successfully treated in 50% of the animals (ED50) following a dose of 0.9 micro-g/g body weight. This was significantly better than ofloxacin and vancomycin.
Route of Administration: Other
In Vitro Use Guide
The antibiotic ability of coumermycin was evaluated against 232 bacterial strains. Minimal inhibitory concentrations (MIC) were determined in trypticase soy broth using twofold serial dilutions. The last tube in a series to show no visible growth after 18 hours at 37 deg-C was considered the MIC. Strain specific MIC's were reported between 0.002 micro-g/L and 100 micro-g/L.
Substance Class Chemical
Created
by admin
on Sat Dec 16 15:52:33 GMT 2023
Edited
by admin
on Sat Dec 16 15:52:33 GMT 2023
Record UNII
PCH9QZ1IIH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
COUMERMYCIN
USAN  
USAN  
Official Name English
COUMAMYCIN
INN  
INN  
Official Name English
1H-PYRROLE-2,4-DICARBOXAMIDE, N2,N4-BIS(7-((6-DEOXY-5-C-METHYL-4-O-METHYL-3-O-((5-METHYL-1H-PYRROL-2-YL)CARBONYL)-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-3-METHYL-
Common Name English
5-METHYLPYYROLE-2-CARBOXYLIC ACID, DIESTER WITH 3,3'-((3-METHYLPYRROLE-2,4-DIYL)BIS(CARBONYLIMINO))BIS(4-HYDROXY-8-METHYL-7-((TETRAHYDRO-3,4-DIHYDROXY-5-METHOXY-6,6-DIMETHYLPYRAN-2-YL)OXY)COUMARIN)
Common Name English
NSC-107412
Code English
coumamycin [INN]
Common Name English
NOTOMYCIN A1
Common Name English
COUMERMYCIN [USAN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C258
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
Code System Code Type Description
CHEBI
3907
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
WIKIPEDIA
Coumermycin A1
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
EPA CompTox
DTXSID901023379
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
SMS_ID
100000084272
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
PUBCHEM
54675768
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
EVMPD
SUB06814MIG
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
NCI_THESAURUS
C81447
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
DRUG BANK
DB13912
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
CAS
4434-05-3
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
MESH
C004628
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
ChEMBL
CHEMBL1908352
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
INN
1948
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
FDA UNII
PCH9QZ1IIH
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
NSC
107412
Created by admin on Sat Dec 16 15:52:33 GMT 2023 , Edited by admin on Sat Dec 16 15:52:33 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY